Literature DB >> 26987995

Bone Material Properties in Osteogenesis Imperfecta.

Nick Bishop1.   

Abstract

Osteogenesis imperfecta entrains changes at every level in bone tissue, from the disorganization of the collagen molecules and mineral platelets within and between collagen fibrils to the macroarchitecture of the whole skeleton. Investigations using an array of sophisticated instruments at multiple scale levels have now determined many aspects of the effect of the disease on the material properties of bone tissue. The brittle nature of bone in osteogenesis imperfecta reflects both increased bone mineralization density-the quantity of mineral in relation to the quantity of matrix within a specific bone volume-and altered matrix-matrix and matrix mineral interactions. Contributions to fracture resistance at multiple scale lengths are discussed, comparing normal and brittle bone. Integrating the available information provides both a better understanding of the effect of current approaches to treatment-largely improved architecture and possibly some macroscale toughening-and indicates potential opportunities for alternative strategies that can influence fracture resistance at longer-length scales.
© 2016 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Year:  2016        PMID: 26987995     DOI: 10.1002/jbmr.2835

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  Finite element analysis of bone strength in osteogenesis imperfecta.

Authors:  Peter Varga; Bettina M Willie; Chris Stephan; Kenneth M Kozloff; Philippe K Zysset
Journal:  Bone       Date:  2020-01-22       Impact factor: 4.398

2.  Applying Full Spectrum Analysis to a Raman Spectroscopic Assessment of Fracture Toughness of Human Cortical Bone.

Authors:  Alexander J Makowski; Mathilde Granke; Oscar D Ayala; Sasidhar Uppuganti; Anita Mahadevan-Jansen; Jeffry S Nyman
Journal:  Appl Spectrosc       Date:  2017-07-14       Impact factor: 2.388

Review 3.  Targeting defective proteostasis in the collagenopathies.

Authors:  Madeline Y Wong; Matthew D Shoulders
Journal:  Curr Opin Chem Biol       Date:  2019-04-24       Impact factor: 8.822

4.  Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.

Authors:  Stéphane Blouin; Nadja Fratzl-Zelman; Francis H Glorieux; Paul Roschger; Klaus Klaushofer; Joan C Marini; Frank Rauch
Journal:  J Bone Miner Res       Date:  2017-06-26       Impact factor: 6.741

5.  Multiscale characterization of pathological bone tissue.

Authors:  E Deniz Eren; Wouter H Nijhuis; Freek van der Weel; Aysegul Dede Eren; Sana Ansari; Paul H H Bomans; Heiner Friedrich; Ralph J Sakkers; Harrie Weinans; Gijsbertus de With
Journal:  Microsc Res Tech       Date:  2021-09-07       Impact factor: 2.893

Review 6.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

7.  Cortical bone properties in the Brtl/+ mouse model of Osteogenesis imperfecta as evidenced by acoustic transmission microscopy.

Authors:  S Blouin; N Fratzl-Zelman; A Roschger; W A Cabral; K Klaushofer; J C Marini; P Fratzl; P Roschger
Journal:  J Mech Behav Biomed Mater       Date:  2018-10-11

8.  Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase.

Authors:  L Bessueille; A Briolay; J Como; S Mebarek; C Mansouri; M Gleizes; A El Jamal; R Buchet; C Dumontet; E L Matera; E Mornet; J L Millan; C Fonta; D Magne
Journal:  Bone       Date:  2020-02-04       Impact factor: 4.398

Review 9.  The Gut Microbiome and Bone Strength.

Authors:  Macy Castaneda; Jasmin M Strong; Denise A Alabi; Christopher J Hernandez
Journal:  Curr Osteoporos Rep       Date:  2020-10-08       Impact factor: 5.096

10.  MicroCT-based phenomics in the zebrafish skeleton reveals virtues of deep phenotyping in a distributed organ system.

Authors:  Matthew Hur; Charlotte A Gistelinck; Philippe Huber; Jane Lee; Marjorie H Thompson; Adrian T Monstad-Rios; Claire J Watson; Sarah K McMenamin; Andy Willaert; David M Parichy; Paul Coucke; Ronald Y Kwon
Journal:  Elife       Date:  2017-09-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.